Management of partial-thickness rotator cuff tears with autologous adipose-derived regenerative cells is safe and more effective than injection of corticosteroid.
Lundeen M., Hurd JL., Hayes M., Hayes M., Facile TR., Furia JP.
Randomized Controlled Trial with a reported sample of 11 on Rotator Cuff, published in Sci Rep (2023) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- Sci Rep (2023)
- Country
- England
- Reported sample size
- 11
- Source database
- PubMed
- PMID
- 37935850
- PMCID
- PMC10630470
- DOI
- 10.1038/s41598-023-46653-4
- NCT
- NCT03752827
- Citations
- 7
Abstract (original English)
Symptomatic, partial-thickness rotator cuff tears (sPTRCT) are problematic. This study tested the hypothesis that management of sPTRCT with injection of fresh, uncultured, unmodified, autologous, adipose-derived regenerative cells (UA-ADRCs) is safe and more effective than injection of corticosteroid even in the long run. To this end, subjects who had completed a former randomized controlled trial were enrolled in the present study. At baseline these subjects had not responded to physical therapy treatments for at least 6 weeks, and were randomly assigned to receive respectively a single injection of UA-ADRCs (n = 11) or a single injection of methylprednisolone (n = 5). Efficacy was assessed using the ASES Total score, pain visual analogue scale (VAS), RAND Short Form-36 Health Survey and range of motion at 33.2 ± 1.0 (mean ± SD) and 40.6 ± 1.9 months post-treatment. Proton density, fat-saturated, T2-weighted MRI of the index shoulder was performed at both study visits. There were no greater risks connected with injection of UA-ADRCs than those connected with injection of corticosteroid. The subjects in the UA-ADRCs group showed statistically significantly higher mean ASES Total scores than the subjects in the corticosteroid group. The MRI scans at 6 months post-treatment allowed to "watch the UA-ADRCs at work".
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level AMeta-analysisEurope PMC
Surgical vs. non-surgical therapy for partial tears of the rotator cuff: a systematic review and meta-analysis of pooled studies with indirect comparison
Meta-analysis with a reported sample of 818 on Tendon Injury, Rotator Cuff, Shoulder Pain, published in BMC Musculoskelet Disord (2026) — summary generated from the PubMed abstract.
- 2026
- n = 818
BMC Musculoskelet Disord - Level AMeta-analysisEurope PMC
Comparison of nonsurgical treatment approaches for partial rotator cuff tears: a systematic review and meta-analysis
Meta-analysis with a reported sample of 137 on Rotator Cuff, Shoulder Pain, published in JSES Rev Rep Tech (2026) — summary generated from the PubMed abstract.
- 2026
- n = 137
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
The role of injections of mesenchymal stem cells as an augmentation tool in rotator cuff repair: a systematic review.
Systematic Review with a reported sample of 5 on Tendon Injury, Rotator Cuff, published in JSES Rev Rep Tech (2025) — summary generated from the PubMed abstract.
- 2025
- n = 5
JSES Rev Rep Tech - Level ASystematic ReviewPubMed
Poor consideration of tissue loading in randomised trials of MSC interventions for tendon pathology: A systematic review using the TIDieR framework.
Systematic Review on Tendon Injury, Rotator Cuff, published in J Exp Orthop (2025) — summary generated from the PubMed abstract.
- 2025
J Exp Orthop - Level AMeta-analysisEurope PMC
Combined arthroscopic rotator cuff repair with mesenchymal stem cell augmentation shows similar functional outcomes but a higher structural integrity rate compared with isolated repair: a meta-analysis of comparative stu
Meta-analysis with a reported sample of 415 on Tendon Injury, Rotator Cuff, published in JSES Int (2025) — summary generated from the PubMed abstract.
- 2025
- n = 415
JSES Int